These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32117766)

  • 1. Evaluation of the National Comprehensive Cancer Network and European Society for Medical Oncology Nasopharyngeal Carcinoma Surveillance Guidelines.
    Zhou GQ; Lv JW; Tang LL; Mao YP; Guo R; Ma J; Sun Y
    Front Oncol; 2020; 10():119. PubMed ID: 32117766
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines.
    Stewart SB; Thompson RH; Psutka SP; Cheville JC; Lohse CM; Boorjian SA; Leibovich BC
    J Clin Oncol; 2014 Dec; 32(36):4059-65. PubMed ID: 25403213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.
    Zagouri F; Liakou P; Bartsch R; Peccatori FA; Tsigginou A; Dimitrakakis C; Zografos GC; Dimopoulos MA; Azim HA
    Breast; 2015 Aug; 24(4):513-23. PubMed ID: 25818651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration.
    Molto C; Hwang TJ; Borrell M; Andres M; Gich I; Barnadas A; Amir E; Kesselheim AS; Tibau A
    Cancer; 2020 Oct; 126(19):4390-4399. PubMed ID: 32697362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology Setting.
    Bentley TGK; Cohen JT; Elkin EB; Huynh J; Mukherjea A; Neville TH; Mei M; Copher R; Knoth R; Popescu I; Lee J; Zambrano JM; Broder MS
    J Manag Care Spec Pharm; 2017 Jun; 23(6-a Suppl):S34-S48. PubMed ID: 28535104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach.
    Stewart-Merrill SB; Boorjian SA; Thompson RH; Psutka SP; Cheville JC; Thapa P; Bergstrahl EJ; Tollefson MK; Frank I
    Urol Oncol; 2015 Aug; 33(8):339.e1-8. PubMed ID: 26031371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancies between NCCN and ESMO guidelines in the management of anal cancer: a qualitative review.
    Johnson N; Pellino G; Simillis C; Qiu S; Nikolaou S; Baird DL; Rasheed S; Tekkis PP; Kontovounisios C
    Updates Surg; 2017 Sep; 69(3):345-349. PubMed ID: 28597183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Masroor F; Corpman D; Carpenter DM; Ritterman Weintraub M; Cheung KHN; Wang KH
    JAMA Otolaryngol Head Neck Surg; 2019 Oct; 145(10):903-908. PubMed ID: 31393552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009.
    Xu Y; Liu H; Chen J; Zhou Q
    Thorac Cancer; 2010 Jul; 1(2):83-86. PubMed ID: 27755782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older.
    Battisti NML; Sehovic M; Extermann M
    Clin Lung Cancer; 2017 Sep; 18(5):460-471. PubMed ID: 28416124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs.
    Bentley TGK; Cohen JT; Elkin EB; Huynh J; Mukherjea A; Neville TH; Mei M; Copher R; Knoth R; Popescu I; Lee J; Zambrano JM; Broder MS
    Value Health; 2017 Feb; 20(2):200-205. PubMed ID: 28237195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression.
    Freeman JL; Kaufmann AB; Everson RG; DeMonte F; Raza SM
    Oper Neurosurg (Hagerstown); 2019 Jan; 16(1):27-36. PubMed ID: 29912434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surveillance after Treatment of Gastrointestinal Cancer].
    Artzner K; Malek NP
    Dtsch Med Wochenschr; 2018 Mar; 143(5):324-333. PubMed ID: 29506299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between adherence to posttreatment National Comprehensive Cancer Network (NCCN) surveillance guidelines and detection of recurrent uterine cancer.
    Mayer CM; O'Connor RM; Do AT; Cerda VR; Wang SM; Scott ME; Li AJ; Rimel BJ; Manuel MR; Taylor KN; Kim KH
    Gynecol Oncol; 2024 Feb; 181():8-11. PubMed ID: 38096674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Comprehensive Cancer Network (NCCN) risk classification in predicting biochemical recurrence after radical prostatectomy: a retrospective cohort study in Chinese prostate cancer patients.
    Xu H; Zhu Y; Dai B; Ye DW
    Asian J Androl; 2018; 20(6):551-554. PubMed ID: 30027928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the cost of CA-125 measurement, physical exam, and imaging in the diagnosis of recurrent ovarian cancer.
    Armstrong A; Otvos B; Singh S; Debernardo R
    Gynecol Oncol; 2013 Dec; 131(3):503-7. PubMed ID: 24060416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines.
    McKenzie E; Zaki P; Raman S; Olson R; McFarlane T; DeAngelis C; Chan S; Pidduck W; Razvi Y; Bushehri A; Chow E
    Support Care Cancer; 2019 Mar; 27(3):783-791. PubMed ID: 30607675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
    Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
    Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.